EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy

Erwen Kou iD, Xiaobei Zhang, Baiping Dong, Bo Wang, Yuanjie Zhu

Life · 23.01.2024 · 14 (2) · 164

DOI: 10.3390/life14020164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 23.01.2024. Verfasst von Erwen Kou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Naval Medical Center, Naval Medical University, Shanghai 200052, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Collaborative Innovation Project, National Natural Science Foundation of China, Basic scientific research project of Naval Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histamine receptor antagonists, which can bind to specific histamine receptors on target cells, exhibit substantial therapeutic efficacy in managing a variety of histamine-mediated disorders. Notably, histamine H1 and H2 receptor antagonists have been extensively investigated and universally acknowledged as recommended treatment agents for numerous allergic diseases and acid-related disorders, respectively. Historically, the combination of H1 and H2 receptor antagonists has been considered a classic treatment strategy, demonstrating relatively superior efficacy compared with single-drug therapies in the treatment of diverse histamine-mediated diseases. The latest emerging studies have additionally suggested the underlying roles of histamine and H1R and H2R in the development of anxiety disorders, arthritic diseases, and postexercise hypotension. Nevertheless, there is still a lack of systematic reviews on the clinical efficacy of combination therapy, greatly limiting our understanding of its clinical application. Here, we present a comprehensive overview of the current knowledge and perspectives regarding the combination of H1 and H2 histamine receptor antagonists in various histamine-mediated disorders. Furthermore, we critically analyze the adverse effects and limitations associated with combination therapy while suggesting potential solutions. Our review can offer a systematic summary and promising insights into the in-depth and effective application of the combination of H1 and H2 receptor antagonists.

Schlagwörter

Stichwörter der Autor:innen

H1 receptorH2 receptorclinical applicationcombination therapyhistaminehistamine receptor antagonistshistamine-mediated diseases

Autor:innen und Institutionen

  • Department of Dermatology, Naval Medical Center, Naval Medical University, Shanghai 200052, China.
  • Department of Pharmacy, Naval Medical Center, Naval Medical University, Shanghai 200052, China.

ORCID-Profile: Erwen Kou

Förderung

  • Shanghai Collaborative Innovation Project
  • National Natural Science Foundation of China
  • Basic scientific research project of Naval Medical University

Zitieren

APA

Kou, E., Zhang, X., Dong, B., Wang, B., & Zhu, Y. (2024). Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy. Life, 14(2), 164. https://doi.org/10.3390/life14020164

Vancouver

Kou E, Zhang X, Dong B, Wang B, Zhu Y. Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy. Life. 2024;14(2):164. doi:10.3390/life14020164

BibTeX
@article{Kou2024,
  author = {Kou, Erwen and Zhang, Xiaobei and Dong, Baiping and Wang, Bo and Zhu, Yuanjie},
  title = {Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {164},
  doi = {10.3390/life14020164}
}
Kostenlos starten →